Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lymphocytes, Tumor-Infiltrating"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 1687
Tytuł:
Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cells.
Autorzy:
Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV) and Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.
Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV) and Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.
Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV) and Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jan; Vol. 13 (1), pp. e1174.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Lymphocytes, Tumor-Infiltrating*
Immunotherapy, Adoptive
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
Autorzy:
Bell PD; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pai RK; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 696-714. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Lymphocyte Count ; Immunity ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients.
Autorzy:
Vaid PM; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Department of Biological Sciences, Ashoka University, Sonipat, India.
Puntambekar AK; Pathology Department, Ruby Hall Clinic, Pune, India.
Jumle NS; Department of Pathology, Jehangir Hospital, Pune, India.
Banale RA; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Ansari D; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Reddy RR; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Unde RR; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Namewar NP; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Kelkar DA; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Shashidhara LS; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Department of Biological Sciences, Ashoka University, Sonipat, India.; Indian Institute of Science Education and Research, Pune, India.
Koppiker CB; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.; Prashanti Cancer Care Mission, Pune, Maharashtra, India.
Kulkarni MD; Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India. .; Prashanti Cancer Care Mission, Pune, Maharashtra, India. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Nov 21; Vol. 17 (1), pp. 91. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes.
Autorzy:
Li CY; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Park HJ; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Shin J; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Baik JE; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mehrara BJ; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kataru RP; The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 03; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Melanoma*/metabolism
Mice ; Humans ; Animals ; Endothelial Cells/metabolism ; Antigen Presentation ; CD8-Positive T-Lymphocytes ; Antigens, Neoplasm/metabolism ; Mice, Transgenic ; Histocompatibility Antigens Class II/metabolism ; CD4-Positive T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade.
Autorzy:
Santinon F; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Ezzahra BF; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Bachais M; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Sarabia Pacis A; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada.
Rudd CE; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada. .; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 02; Vol. 12 (1), pp. 18509. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Neoplasms*/pathology
Humans ; Programmed Cell Death 1 Receptor/metabolism ; Interferon-gamma/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels.
Autorzy:
Ugai T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Liu L; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology and Biostatistics, and the Ministry of Education Key Lab of Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.; Hubei Cancer Hospital Wuhan, Hubei, P.R. China.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Tabung FK; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Hamada T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Langworthy BW; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Akimoto N; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Haruki K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Takashima Y; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Okadome K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kawamura H; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Zhao M; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kahaki SMM; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Glickman JN; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Lennerz JK; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Zhang X; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Chan AT; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Fuchs CS; Genentech, South San Francisco, California, USA.
Song M; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wang M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Nowak JA; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Wu K; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Ogino S; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Cancer Immunology Program, Dana-Farber / Harvard Cancer Center, Boston, Massachusetts, USA.
Giovannucci EL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Nov; Vol. 12 (11), pp. e1114.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Follow-Up Studies ; Diet/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of stromal PD-L1 expression in colorectal liver metastasis.
Autorzy:
Takasu C; Department of Surgery, Tokushima University, Tokushima, Japan. .
Morine Y; Department of Surgery, Tokushima University, Tokushima, Japan.
Yoshikawa K; Department of Surgery, Tokushima University, Tokushima, Japan.
Nakao T; Department of Surgery, Tokushima University, Tokushima, Japan.
Tokunaga T; Department of Surgery, Tokushima University, Tokushima, Japan.
Nishi M; Department of Surgery, Tokushima University, Tokushima, Japan.
Kashihara H; Department of Surgery, Tokushima University, Tokushima, Japan.
Wada Y; Department of Surgery, Tokushima University, Tokushima, Japan.
Yoshimoto T; Department of Surgery, Tokushima University, Tokushima, Japan.
Shimada M; Department of Surgery, Tokushima University, Tokushima, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 17; Vol. 24 (1), pp. 97. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Liver Neoplasms*/pathology
Humans ; B7-H1 Antigen ; Immune Checkpoint Inhibitors ; Lymphocytes, Tumor-Infiltrating ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs.
Autorzy:
Ahmadvand S; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Norouzi LA; Otolaryngology Research Centre, Department of Otorhinolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammadi Y; Shiraz Institute for Cancer Research, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Safaei A; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Khademi B; Otolaryngology Research Centre, Department of Otorhinolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
Motiee-Langroudi M; Otorhinolaryngology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Ghaderi A; Shiraz Institute for Cancer Research, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2024 Jan 16; Vol. 25 (1), pp. 7. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*
Larynx*/chemistry
Larynx*/metabolism
Larynx*/pathology
Tongue Neoplasms*/metabolism
Tongue Neoplasms*/pathology
Humans ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/metabolism ; Lymphocytes, Tumor-Infiltrating/metabolism ; Prognosis ; Programmed Cell Death 1 Receptor/metabolism ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Squamous Cell Carcinoma of Head and Neck/pathology ; Tongue/chemistry ; Tongue/metabolism ; Tongue/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model.
Autorzy:
Zaki HM; Zoology Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Ali KM; Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Abd Allah MYY; Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Abouelnaga AM; Zoology Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Abdraboh ME; Zoology Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Hussein O; Surgical Oncology Department, Faculty of Medicine, Mansoura University Oncology Center, Mansoura University, Mansoura, 35516, Egypt. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2024 Jan 02; Vol. 17 (1), pp. 4. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Carcinoma*/drug therapy
Mice ; Animals ; Lymphocytes, Tumor-Infiltrating ; Retrospective Studies ; Administration, Metronomic ; Cyclophosphamide ; Drug Combinations ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
Autorzy:
Xing J; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Gu Y; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Song Y; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi Province, People's Republic of China.
Liu Q; Department of ophthalmology and otorhinolaryngology, the first hospital in Weinan, No. 35, Shengli Street, Linwei District, Weinan City, 714000, Shaanxi Province, China.
Chen Q; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Han P; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Shen Z; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Li H; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Zhang S; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Bai Y; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China.
Ma J; School of Information Engineering, Chang'an University, Xi'an, 710061, China. .
Sui F; Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yan-ta West Road, Xi'an, 710061, Shaanxi, China. sf_.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 21; Vol. 23 (1), pp. 1267. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
Papillomavirus Infections*
Myosin Type V*/genetics
Humans ; Vimentin/genetics ; Squamous Cell Carcinoma of Head and Neck/genetics ; Neoplastic Processes ; Prognosis ; Lymphocytes, Tumor-Infiltrating ; Myosin Heavy Chains/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preliminary analysis of immune-related markers in thymic carcinoid.
Autorzy:
Zhang J; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Guo C; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Liu L; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Zhao K; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Zhou M; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Chen Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Li S; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Dec 09; Vol. 21 (1), pp. 894. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Letter
MeSH Terms:
CD8-Positive T-Lymphocytes*/metabolism
Carcinoid Tumor*/metabolism
Humans ; B7-H1 Antigen/metabolism ; Tumor Microenvironment ; Lymphocytes, Tumor-Infiltrating/metabolism ; Prognosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Autorzy:
Li Q; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
Zhu J; Department of Urology Surgery, The First Affiliated Hospital of Dali University, Yunnan, China.
Zhang Y; Department of General Surgery, The First Affiliated Hospital of Dali University, Yunnan, China.
Pan Y; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
Li Z; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
Wang M; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
Gao Y; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
Feng D; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China.
He X; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Dali University, Yunnan, China.
Zhang C; Department of Pathology, The First Affiliated Hospital of Dali University, Yunnan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 07; Vol. 13 (1), pp. 21629. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms, Castration-Resistant*/genetics
Prostatic Hyperplasia*/pathology
Prostatic Neoplasms*/pathology
Prostatic Intraepithelial Neoplasia*
Male ; Humans ; T-Lymphocytes/metabolism ; Prognosis ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Autorzy:
Zheng J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Zhang H; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Li S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Kang Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; College of Computer and Data Science, Fuzhou University, Fuzhou, 350025, China.
Zheng F; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Yao Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Zhang X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Wu Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Wang J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Fang W; Department of Thoracic Surgery Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Li J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Chen G; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Chen Y; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, 350001, China. .
Chen M; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 05; Vol. 23 (1), pp. 1193. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Neoplasms*/therapy
Esophageal Neoplasms*/pathology
Humans ; Prognosis ; Eosine Yellowish-(YS) ; Hematoxylin ; Lymphocytes, Tumor-Infiltrating/pathology ; Retrospective Studies ; Chemoradiotherapy/methods ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
Autorzy:
Huertas-Caro CA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.
Ramírez MA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.
Rey-Vargas L; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.
Bejarano-Rivera LM; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.
Ballen DF; Clinical Oncology Unit. Instituto Nacional de Cancerología and Adjunct Clinical Professor, Pontificia Universidad Javeriana, Bogotá, DC, Colombia.
Nuñez M; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia.
Mejía JC; Grupo de Patología, Instituto Nacional de Cancerología, Bogotá, Colombia.
Sua-Villegas LF; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia.
Cock-Rada A; Department of Oncological Breast Surgery and Mastology, Instituto de Cancerología Las Américas, Medellín, Colombia.
Zabaleta J; Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Fejerman L; Department of Public Health Sciences, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.
Sanabria-Salas MC; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.
Serrano-Gomez SJ; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia. .; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 03; Vol. 13 (1), pp. 21324. Date of Electronic Publication: 2023 Dec 03.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/pathology
Humans ; Lymphocytes, Tumor-Infiltrating ; Colombia ; Prognosis ; Biomarkers ; Biomarkers, Tumor/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer.
Autorzy:
Reznitsky FM; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.; Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.
Jensen JD; Department of Oncology, Odense University Hospital, Funen, Denmark.
Knoop A; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Jensen MB; Danish Breast Cancer Group, Copenhagen University Hospital, Copenhagen, Denmark.
Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1913-1920. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Prognosis ; Class I Phosphatidylinositol 3-Kinases/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.
Autorzy:
Landén AH; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Chin K; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kovács A; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Molnar E; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stenmark Tullberg A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Wärnberg F; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1862-1872. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/etiology
Carcinoma*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating/pathology ; Breast Density ; Neoadjuvant Therapy/methods ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer.
Autorzy:
Kim T; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Lim H; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Jun S; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Park J; Department of Obstetrics and Gynecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Lee D; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Lee JH; Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Korea.; Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Korea.
Lee JY; Department of Obstetrics and Gynecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Bang D; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20485. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/genetics
Endometrial Neoplasms*/genetics
Humans ; Female ; BRCA1 Protein ; Lymphocytes, Tumor-Infiltrating ; BRCA2 Protein ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas.
Autorzy:
Machuca-Aguado J; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Conde-Martín AF; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Alvarez-Muñoz A; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Rodríguez-Zarco E; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Polo-Velasco A; Gynecology Department, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Rueda-Ramos A; Oncology Department, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Rendón-García R; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Ríos-Martin JJ; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Idoate MA; Department of Pathology, Virgen Macarena University Hospital & School of Medicine, University of Seville, 41009 Seville, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 07; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/pathology
Carcinoma*/pathology
Female ; Humans ; Lymphocytes, Tumor-Infiltrating ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cost-effectiveness analysis of tumor-infiltrating lymphocytes biomarkers guiding chemotherapy de-escalation in early triple-negative breast cancer.
Autorzy:
Li S; Department of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Liu Y; Shanghai Health Development Research Centre (Shanghai Medical Information Centre), Shanghai, China.
Zhang P; Department of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Wang M; The Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Sun L; Department of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 21001-21012. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Cost-Effectiveness Analysis*
Triple Negative Breast Neoplasms*/drug therapy
Humans ; Middle Aged ; Biomarkers, Tumor ; Cost-Benefit Analysis ; Lymphocytes, Tumor-Infiltrating ; Neoplasm Recurrence, Local ; Female
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma.
Autorzy:
Esmeray Sönmez E; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Hatipoğlu T; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Kurşun D; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Hu X; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.
Akman B; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.
Yuan H; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, İzmir 35340, Türkiye.
Erşen Danyeli A; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; Department of Pathology, Acıbadem University Altunizade Hospital, İstanbul 34662, Türkiye.
Alacacıoğlu İ; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Özkal S; Department of Pathology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Olgun A; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.; İzmir Tepecik Research and Training Hospital, Health Sciences University, İzmir 35020, Türkiye.
Erdağ TK; Department of Otorhinolaryngology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
You H; Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, Department of Hematology and Oncology, Children's Hospital of Chongqing Medical University, Chongqing 401122, China.; International Science and Technology Cooperation Base of Child Development and Critical Disorders, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing 401122, China.
Küçük C; İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35340, Türkiye.; Basic and Translational Research Program, İzmir Biomedicine and Genome Center, İzmir 35340, Türkiye.; Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35340, Türkiye.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 27; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Mantle-Cell*/genetics
RNA, Long Noncoding*/genetics
Lymphocytes, Tumor-Infiltrating*/metabolism
Adult ; Humans ; Carcinogenesis ; CD8-Positive T-Lymphocytes/metabolism ; RNA, Messenger/genetics ; von Willebrand Factor ; Exome Sequencing ; Biomarkers, Tumor/genetics ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 1687

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies